# Arcadia Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/arcadia-biosciences

- Industry: Agribusiness
- Headquarters: Davis, US
- Website: www.arcadiabio.com
- Total disclosed funding: $48M
- Latest round: Series D (May 8, 2014)
- Investors on record: 5

## About

Arcadia Biosciences, Inc. focuses on developing innovative specialty wheat ingredients and health-oriented products aimed at improving nutritional quality and health benefits for consumers.Arcadia Biosciences, Inc. was founded in 2002 and is headquartered in Davis, US. The company specializes in agricultural biotechnology, particularly in the enhancement of wheat varieties. In March 2023, Arcadia raised USD 6.00 mn through a Private Placement to support its growth initiatives. The company's leadership includes CEOs Matt Plavan and Stan Jacot. It operates with a total of 9 deals to date and has a specific focus on developing new products and enhancing its operational strategies.Arcadia Biosciences specializes in developing specialty wheat ingredients that enhance nutritional profiles and health benefits. Their offerings include wheat varieties with increased fiber content, improved protein quality, and reduced allergenic gluten, designed for health-conscious consumers. Additionally, they market Zola coconut water, known for its hydration and electrolyte properties, targeting North America and select international markets.In the most recent fiscal year 2024, Arcadia Biosciences reported a revenue of USD 5.05 mn and an EBITDA of USD -3.65 mn. The company generates revenue primarily through B2B partnerships with food manufacturers for its specialty wheat ingredients, as well as retail distribution of Zola coconut water, catering directly to consumers seeking healthy beverage options.Following the recent funding round completed in March 2023, which raised USD 6.00 mn, Arcadia plans to invest in Project Greenfield, aiming to build its GoodWheatTM family of brands and expand its e-commerce and direct-to-consumer marketing infrastructure. The company is also set to launch its Three Farm DaughtersTM branded pasta and flour products and fund its Archipelago VenturesTM operations for hemp cultivation and CBD extraction. These initiatives are expected to enhance Arcadia's market presence in health and wellness segments.

## Funding rounds

- Series D, May 8, 2014, $33M — Saints Capital, Presidio Partners, BASF, Mandala Capital
- Series B, Dec 1, 2008, $15M — Saints Capital, Presidio Partners, BASF, Exeter Life Science

## Investors

- Saints Capital (https://capitalatlas.ai/funds/saints-capital) — Series B, Series D
- Presidio Partners (https://capitalatlas.ai/funds/presidio-partners) — Series B, Series D
- BASF (https://capitalatlas.ai/funds/basf) — Series B, Series D
- Exeter Life Science — Series B
- Mandala Capital (https://capitalatlas.ai/funds/mandala-capital) — Series D